Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 7, 2020; 26(45): 7153-7172
Published online Dec 7, 2020. doi: 10.3748/wjg.v26.i45.7153
Published online Dec 7, 2020. doi: 10.3748/wjg.v26.i45.7153
Figure 4 Linear discriminant analysis effect size analysis of fecal bacterial of patients with diarrhea-predominant irritable bowel syndrome and healthy controls.
A: The cladogram showed enriched taxa in the irritable bowel syndrome with predominant diarrhea (IBS-D) group (blue) and the healthy control (HC) group (yellow); the taxa represented by the English letters in the cladogram are shown in the legend on the right; B: Taxa enriched in the IBS-D group are indicated with a positive linear discriminant analysis (LDA) score (blue) and taxa enriched in the HC group are indicated with a negative score (yellow); only taxa with LDA effect size (LEfSe) P values < 0.05 and LDA scores ≥ 2.0 are presented.
- Citation: Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2020; 26(45): 7153-7172
- URL: https://www.wjgnet.com/1007-9327/full/v26/i45/7153.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i45.7153